ETFsXtrackers MSCI Fintech Innovation UCITS ETF 1C
Xtrackers
Xtrackers MSCI Fintech Innovation UCITS ETF 1C
XFNT LSEAccumulatingIreland
Last close · EUR
42.64EUR
-3.24% · -€1.43
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
XFNTBase
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- -8.0%
- Sharpe 3Y
- 0.67
- Volatility 1Y
- 18.0%annualised
- Holdings
- 100Fund holdings
Performance
Compare
- XFNT-8.0%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| XFNT | -3.2% | +0.2% | +8.8% | -0.9% | -8.0% | +56.1% | - |
| MSCI World | +0.4% | +4.9% | +10.8% | +16.3% | +15.9% | +75.5% | +71.2% |
| Gap to MSCI World | -3.6% | -4.7% | -2.0% | -17.2% | -23.9% | -19.4% | - |
Risk and return
Sharpe ratio · 3Y
0.67
Below MSCI World · 1.24- Return p.a.
- +14.3%
- Volatility
- 18.3%
- Max loss
- -26.0%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
XFNT
0.67
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 43.2%
- Holdings
- 100
- As of
- 1VISA CLASS AUS92826C83945.36%
- 2MASTERCARD CLASS AUS57636Q10405.27%
- 3APPLEUS03783310055.15%
- 4CROWDSTRIKE HOLDINGS CLASS AUS22788C10534.97%
- 5NVIDIAUS67066G10404.46%
- 6TENCENT HOLDINGSKYG8757216343.87%
- 7CME GROUP CLASS AUS12572Q10583.80%
- 8ALIBABA GROUP HOLDING ADR REPRESENUS01609W10273.60%
- 9INTEL CORPORATION CORPUS45814010013.36%
- 10AMERICAN EXPRESSUS02581610923.32%
Countries
Classified 100.0%
United States73.3%
China12.6%
BR
IN
- Largest
- 73.3%United States
- Top 3
- 90.9%
- Effective number
- 1.81 / HHI
Market cap
Weight vs holdings
43.2%of the fund sits in the top 10 holdings
43.2%46.5%10.3%
WeightHoldings
104050
- Holdings 1-10
- Holdings 11-50
- Holdings 51-100
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
